Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor

Cited by (410)

Items 101–200 of 410

1. 17β‐estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo
   Laura A. Laviolette, Kendra M. Hodgkinson, Neha Minhas, Carol Perez‐Iratxeta, Barbara C. Vanderhyden · 2014 · International Journal of Cancer
2. Nuclear receptors and chromatin: an inducible couple
   Raffaella Maria Gadaleta, Luca Magnani · 2013 · Journal of Molecular Endocrinology
3. Akt regulates progesterone receptor B-dependent transcription and angiogenesis in endometrial cancer cells
   Irene I. Lee, Kruti P. Maniar, John P. Lydon, Julie J. Kim · 2016 · Oncogene
4. Growth regulation by estrogen in breast cancer 1 (GREB1) is a novel progesterone-responsive gene required for human endometrial stromal decidualization
   Alison J. Camden, Maria M. Szwarc, Sangappa Basanna Chadchan, Francesco John DeMayo, Bert W. O’Malley, John P. Lydon, Ramakrishna Kommagani · 2017 · Molecular Human Reproduction
5. Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer.
   Eylem Kulkoyluoglu, Zeynep Madak-Erdogan · 2016 · Steroids
6. Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure
   Masahiro Oka, Mayumi Otani, Yoichi Miyamoto, Rieko Oshima, Jun Adachi, Takeshi Tomonaga, Munehiro Asally, Yuya Nagaoka, Kaori Y. Tanaka, Atsushi Toyoda et al. · 2023 · Cell Reports
7. Genetic regulation of methylation in human endometrium and blood and gene targets for reproductive diseases
   Sally Mortlock, Restuadi Restuadi, Rupert Levien, Jane E. Girling, Sarah J. Holdsworth‐Carson, Martin Healey, Zhihong Zhu, Ting Qi, Yang Wu, Samuel W. Lukowski et al. · 2019 · Clinical Epigenetics
8. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling
   Shinji Matsumoto, Taku Yamamichi, Koei Shinzawa, Yuuya Kasahara, Satoshi Nojima, Takahiro Kodama, Satoshi Obika, Tetsuo Takehara, Eiichi Morii, Hiroomi Okuyama et al. · 2019 · Nature Communications
9. Transcriptional coregualtor NUPR1 maintains tamoxifen resistance in breast cancer cells
   Lingling Wang, Jiashen Sun, Yueyuan Yin, Yanan Sun, Jinyi Ma, Ruimin Zhou, Xinzhong Chang, Li Ding, Zhi Yao, Shanshan Tian et al. · 2021 · Cell Death and Disease
10. Androgen and glucocorticoid receptor direct distinct transcriptional programs by receptor-specific and shared DNA binding sites
    Marina Kulik, Melissa Bothe, Gözde Kibar, Alisa Fuchs, Stefanie Schöne, Stefan Preković, Isabel Mayayo‐Peralta, Ho‐Ryun Chung, Wilbert T. Zwart, Christine Helsen et al. · 2021 · Nucleic Acids Research
11. Cytosine modifications modulate the chromatin architecture of transcriptional enhancers
    Elise A. Mahé, Thierry Madigou, Aurélien A. Sérandour, Maud Bizot, Stéphane Avner, Frédéric Chalmel, Gaëlle Palierne, Raphaël Métivier, Gilles Salbert · 2017 · Genome Research
12. Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogenec-KITand amplifies cell proliferation
    Lydie L. Debaize, Hélène Jakobczyk, Stéphane Avner, Jérémie Rouger, Anne-Gaëlle Rio, Aurélien A. Sérandour, Lena Dorsheimer, Frédéric Chalmel, Jason S. Carroll, Martin Zörnig et al. · 2018 · Nucleic Acids Research
13. GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer
    Eun Myoung Shin, Vinh Thang Huynh, Sultan Abda Neja, Chia Yi Liu, Anandhkumar Raju, Kelly Yu Sing Tan, Nguan Soon Tan, Jayantha Gunaratne, Xuezhi Bi, Lakshminarayan M. Iyer et al. · 2021 · Science Advances
14. Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer
    Alacoque L. Browne, Sara Charmsaz, Damir Varešlija, Ailís Fagan, Nicola S. Cosgrove, Sinéad Cocchiglia, Siobhan P. Purcell, Elspeth Ward, Fiona T. Bane, Lance Hudson et al. · 2018 · Oncogene
15. VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer
    Andrew N. Holding, Federico Manuel Giorgi, Amanda Donnelly, Amy E Cullen, Sankari Nagarajan, Luke A. Selth, Florian M. Markowetz · 2019 · Genome biology
16. Estrogen receptor-mediated long-range chromatin interactions and transcription in breast cancer
    Mei Hui Liu, Edwin Chong Wing Cheung · 2013 · Molecular and Cellular Endocrinology
17. Pushing estrogen receptor around in breast cancer
    Elgene Lim, Gerard A. Tarulli, Neil Portman, Theresa E. Hickey, Wayne D. Tilley, Carlo Palmieri · 2016 · Endocrine Related Cancer
18. Sex Differences in the Epigenome: A Cause or Consequence of Sexual Differentiation of the Brain?
    Bruno Gegenhuber, Jessica Tollkühn · 2019 · Genes
19. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration
    Thilde Terkelsen, Francesco Russo, Pavel Gromov, Vilde Drageset Haakensen, Søren Brunak, Irina Gromova, Anders Krogh, Elena Papaleo · 2020 · Breast Cancer Research
20. TRPS1 regulates oestrogen receptor binding and histone acetylation at enhancers
    Aurélien A. Sérandour, Hisham Mohammed, Ahmad Miremadi, K. W. Mulder, Jason S. Carroll · 2018 · Oncogene
21. Grainyhead-like Protein 2: The Emerging Role in Hormone-Dependent Cancers and Epigenetics
    Rebecca Reese, Melissa M. Harrison, Elaine T. Alarid · 2019 · Endocrinology
22. MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer
    Michael J. G. Milevskiy, Udai Gujral, Carolina Marques, Andrew M. Stone, Korinne S. Northwood, Lez J. Burke, Julia M.W. Gee, Kenneth P. Nephew, Susan J. Clark, Melissa A. Brown · 2019 · British Journal of Cancer
23. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance
    Yi Yu-Rice, Yanli Jin, B Han, Ying Qu, Jeffrey E. Johnson, Takaaki Watanabe, Long Cheng, Nan Deng, Hisashi Tanaka, Bowen Gao et al. · 2016 · Oncogene
24. Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer
    Laura Cato, Antje Neeb, Adam Sharp, Víctor Buzón, Scott B. Ficarro, Linxiao Yang, Claudia Muhle‐Goll, Nane C Kuznik, Ruth Riisnaes, Daniel Nava Rodrigues et al. · 2017 · eLife
25. The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei
    Giovanni Nassa, Giorgio Giurato, Annamaria Salvati, Valerio Gigantino, Giovanni Pecoraro, Jessica Lamberti, Francesca Maria Rizzo, Tuula A. Nyman, Roberta Tarallo, Alessandro Weisz · 2019 · Scientific Data
26. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha
    Seth E. Frietze, Henriette O’Geen, Laurie E. Littlepage, Catalina Simion, Colleen A. Sweeney, Peggy Farnham, Sheryl R. Krig · 2014 · BMC Genomics
27. The transcriptional co-repressor TLE3 suppresses basal signaling on a subset of estrogen receptor α target genes
    Maïka Jangal, Jean-Philippe Couture, Stéphanie Bianco, Luca Magnani, Hisham Mohammed, Nicolas Y. Gévry · 2014 · Nucleic Acids Research
28. The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2
    Kyle T. Helzer, Mary Szatkowski Ozers, Mark B. Meyer, Nancy A. Benkusky, Natalia M. Solodin, Rebecca Reese, Christopher L. Warren, John Wesley Pike, Elaine T. Alarid · 2018 · Molecular and Cellular Biology
29. The Contribution of Mass Spectrometry-Based Proteomics to Understanding Epigenetics
    Roberta Noberini, Gianluca Sigismondo, Tiziana Bonaldi · 2015 · Epigenomics
30. Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers
    Suzan Stelloo, Andries Marinus Bergman, Wilbert T. Zwart · 2019 · Endocrine Related Cancer
31. Estrogen Receptor Covalent Antagonists: The Best Is Yet to Come
    Craig Furman, Ming‐Hong Hao, Sudeep Prajapati, Dominic J. Reynolds, Victoria M. Rimkunas, Guo Zhu Zheng, Ping Zhu, Manav Korpal · 2019 · Cancer Research
32. Serine-Phosphorylated STAT3 Promotes Tumorigenesis via Modulation of RNA Polymerase Transcriptional Activity
    Jesse J. Balic, Daniel J. Garama, Mohamed I. Saad, Liang Yu, Alison C. West, Alice J. West, Thaleia Livis, Prithi S. Bhathal, Daniel J. Gough, Brendan John Jenkins · 2019 · Cancer Research
33. The Groucho Co-repressor Is Primarily Recruited to Local Target Sites in Active Chromatin to Attenuate Transcription
    Aamna K Kaul, Eugene F. Schuster, Barbara H. Jennings · 2014 · PLoS Genetics
34. Ctr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis
    Hao Zeng, Wei Xu · 2015 · Genes & Development
35. Tagmentation-based single-cell genomics
    Andrew Adey · 2021 · Genome Research
36. LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer
    Yichen Xu, Hua Zhang, Van T.M. Nguyen, Nicos Angelopoulos, João Nunes, Alistair G. Reid, Laki Buluwela, Luca Magnani, Justin Stebbing, Georgios Giamas · 2015 · Cell Reports
37. ER-positive breast cancer cells are poised for RET-mediated endocrine resistance
    Sachi Horibata, Edward J. Rice, Chinatsu Mukai, Brooke A. Marks, Kelly L. Sams, Hui Zheng, Lynne J. Anguish, Scott Alexander Coonrod, Charles G. Danko · 2018 · PLoS ONE
38. Shift from androgen to estrogen action causes abdominal muscle fibrosis, atrophy, and inguinal hernia in a transgenic male mouse model
    Hong Zhao, Ling Zhou, Chunlin Li, John Sayler Coon, Robert Treat Chatterton, David C. Brooks, Enze Jiang, Li Liu, Xia Xu, Zhiyong Dong et al. · 2018 · Proceedings of the National Academy of Sciences
39. Recurrent uterine tumors resembling ovarian sex-cord tumors with the growth regulation by estrogen in breast cancer 1-nuclear receptor coactivator 2 fusion gene: a case report and literature review
    Bin Chang, Qianming Bai, Lin Liang, Huijuan Ge, Qianlan Yao · 2020 · Diagnostic Pathology
40. Complex Formation and Function of Estrogen Receptor α in Transcription Requires RIP140
    Meritxell Rosell, Ekaterina Nevedomskaya, Suzan Stelloo, Jaya Nautiyal, Ariel Poliandri, Jennifer H. Steel, Lodewyk F.A. Wessels, Jason S. Carroll, Malcolm G. Parker, Wilbert T. Zwart · 2014 · Cancer Research
41. PAN RNA: transcriptional exhaust from a viral engine
    Mel Campbell, Yoshihiro Izumiya · 2020 · Journal of Biomedical Science
42. Chromatin Proteomics to Study Epigenetics — Challenges and Opportunities
    Guido van Mierlo, Michiel Vermeulen · 2020 · Molecular & Cellular Proteomics
43. Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies
    Kristina Veskimäe, Mauro Scaravilli, Wilhelmiina Niininen, Hanna Karvonen, Serafiina Jaatinen, Matti Nykter, Tapio Visakorpi, Johanna Unelma Maenpaa, Daniela Ungureanu, Synnöve M. Staff · 2018 · Translational Oncology
44. The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms
    Chao‐Hui Chang, Feng Liu, Stefania Militi, Svenja S. Hester, Reshma Nibhani, Siwei Deng, James E. Dunford, Aniko Rendek, Zahir F. Soonawalla, Román Fischer et al. · 2024 · Nature Communications
45. The “busy life” of unliganded estrogen receptors
    Claudia Stellato, Immacolata Porreca, Danila Cuomo, Roberta Tarallo, Giovanni Nassa, Concetta Ambrosino · 2015 · PROTEOMICS
46. The FACT complex facilitates expression of lysosomal and antioxidant genes through binding to TFEB and TFE3
    Eutteum Jeong, José A. Martina, Pablo S. Contreras, Juhyung Lee, Rosa Puertollano · 2022 · Autophagy
47. The histone modification reader ZCWPW1 promotes double-strand break repair by regulating cross-talk of histone modifications and chromatin accessibility at meiotic hotspots
    Shenli Yuan, Tao Huang, Ziyou Bao, Shiyu Wang, Xinyue Wu, Jiang Liu, Hongbin Liu, Zi‐Jiang Chen · 2022 · Genome biology
48. A GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis
    Sangappa Basanna Chadchan, Pooja Popli, Zian Liao, Eryk Andreas, Michelle Dias, Tianyuan Wang, Stephanie Gunderson, Patricia T. Jimenez, Denise Grant Lanza, Rainer B. Lanz et al. · 2024 · Nature Communications
49. Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype
    Damir Varešlija, Elspeth Ward, Siobhan P. Purcell, Nicola S. Cosgrove, Sinéad Cocchiglia, Philip J. O’Halloran, Sara Charmsaz, Fiona T. Bane, Francesca M. Brett, Michael A. Farrell et al. · 2021 · Oncogene
50. Methylated miRNAs may serve as potential biomarkers and therapeutic targets for hidradenitis suppurativa
    Uppala Radhakrishna, Uppala Ratnamala, Devendrasinh Jhala, Nikita Vadsaria, Maulikkumar Patel, Lavanya V. Uppala, Sangeetha Vishweswaraiah, Aaren Vedangi, Nazia Saiyed, Giovanni Battista Damiani et al. · 2022 · Journal of the European Academy of Dermatology and Venereology
51. O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer
    Gloria M. Trinca, Merit L. Goodman, Evangelia K. Papachristou, Clive S. D’Santos, Prabhakar Chalise, Rashna Madan, Chad M Slawson, Christy R. Hagan · 2017 · Hormones and Cancer
52. Alteration of Mammary Gland Development and Gene Expression by In Utero Exposure to Cadmium
    Daniela A. Parodi, Morgan Greenfield, Claire Evans, Anna M. Chichura, Alexandra Alpaugh, James Koudy Williams, Kedra Cyrus, Mary C. Martin · 2017 · International Journal of Molecular Sciences
53. Distribution of genetic variation underlying adult migration timing in steelhead of the Columbia River basin
    E. E. Collins, John S. Hargrove, Thomas A. Delomas, S. Narum · 2020 · Ecology and Evolution
54. GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance
    Eugine Lee, John Wongvipat, Danielle Choi, Ping Wang, Young Sun Lee, Deyou Zheng, Philip A. Watson, Anuradha Gopalan, Charles L. Sawyers · 2019 · eLife
55. A Cross-Linking-Aided Immunoprecipitation/Mass Spectrometry Workflow Reveals Extensive Intracellular Trafficking in Time-Resolved, Signal-Dependent Epidermal Growth Factor Receptor Proteome
    Yue Chen, Mei Leng, Yankun Gao, Dongdong Zhan, Jong Min Choi, Lei Song, Kai Li, Xia Xia, Chunchao Zhang, Mingwei Liu et al. · 2019 · Journal of Proteome Research
56. An update of molecular findings in uterine tumor resembling ovarian sex cord tumor and GREB1 ‐rearranged uterine sarcoma with variable sex‐cord differentiation
    Yu‐Chien Kao, Jen‐Chieh Lee · 2020 · Genes Chromosomes and Cancer
57. A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations
    Roser Zaurín, Roberto Ferrari, Ana Silvina Nacht, José Carbonell‐Caballero, François Le Dily, Jofre Font-Mateu, Lara de Llobet, Enrique Vidal, Antonios Lioutas, Miguel Beato et al. · 2021 · Nucleic Acids Research
58. A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer
    Emanuela Dylgjeri, Vishal Kothari, Ayesha A. Shafi, Galina Semenova, Peter T. Gallagher, Yi Fang Guan, Angel Pang, Jonathan F. Goodwin, Swati Irani, Jennifer J. McCann et al. · 2022 · Clinical Cancer Research
59. Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity
    Stefan Preković, Theofilos Chalkiadakis, Merel Roest, Daniel Lee Roden, Catrin Lutz, Karianne G. Schuurman, Mark Opdam, Liesbeth Hoekman, Nina Abbott, Tanja Tesselaar et al. · 2023 · EMBO Molecular Medicine
60. Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumors
    Marjolein Droog, Ekaterina Nevedomskaya, Gwen M. H. E. Dackus, Renske Fles, Yongsoo Kim, Harry Hollema, Marian J.E. Mourits, Petra M. Nederlof, Hester H. van Boven, Sabine C. Linn et al. · 2017 · Proceedings of the National Academy of Sciences
61. PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer
    Anran Chen, Beom-Jun Kim, Aparna Mitra, Craig T. Vollert, Jonathan Thomas Lei, Diana M. Fandino, Meenakshi Anurag, Matthew Valle Holt, Xuxu Gou, Jacob B. Pilcher et al. · 2024 · Molecular Cancer Therapeutics
62. The Multifactorial Pathogenesis of Endometriosis: A Narrative Review Integrating Hormonal, Immune, and Microbiome Aspects
    Zaure Datkhayeva, Ainur Iskakova, Alla Mireeva, Aida Seitaliyeva, Raikhan Skakova, Gulshat Kulniyazova, Aiman Shayakhmetova, Gaukhar Koshkimbayeva, Chapen Sarmuldayeva, Lazzat Nurseitova et al. · 2025 · Medicina
63. 3CPET: finding co-factor complexes from ChIA-PET data using a hierarchical Dirichlet process
    Mohamed Nadhir Djekidel, Zhengyu Liang, Qi Wang, Zhirui Hu, Guipeng Li, Yang Chen, Michael Q. Zhang · 2015 · Genome biology
64. Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA
    Tatsuro Yamamoto, Chiyomi Sakamoto, Hiroaki Tachiwana, Mitsuru Kumabe, Toshiro Matsui, Tadatoshi Yamashita, Masatoshi Shinagawa, Koji Ochiai, Noriko Saitoh, Mitsuyoshi Nakao · 2018 · Scientific Reports
65. Inside the supergene of the bird with four sexes
    Donna L. Maney, Jennifer R. Merritt, Mackenzie R. Prichard, Brent M. Horton, Soojin V. Yi · 2020 · Hormones and Behavior
66. Wnt/β-catenin signaling pathway in liver biology and tumorigenesis
    Shinji Matsumoto, Akira Kikuchi · 2024 · In Vitro Cellular & Developmental Biology - Animal
67. BioTAP‐XL: Cross‐linking/Tandem Affinity Purification to Study DNA Targets, RNA, and Protein Components of Chromatin‐Associated Complexes
    Artyom A. Alekseyenko, Kyle A. McElroy, Hyuckjoon Kang, Barry M. Zee, Peter V. Kharchenko, Mitzi I. Kuroda · 2015 · Current Protocols in Molecular Biology
68. Chromatin reprogramming in breast cancer
    Erin E. Swinstead, Ville Paakinaho, Gordon L. Hager · 2018 · Endocrine Related Cancer
69. Consideration of GREB1 as a potential therapeutic target for hormone-responsive or endocrine-resistant cancers
    Kendra M. Hodgkinson, Barbara C. Vanderhyden · 2014 · Expert Opinion on Therapeutic Targets
70. Functional coordination of BET family proteins underlies altered transcription associated with memory impairment in fragile X syndrome
    Seung-Kyoon Kim, Xihui Liu, Jongmin Park, Dahun Um, Gokhul Kilaru, Cheng‐Ming Chiang, Mingon Kang, Kimberly M. Huber, Keunsoo Kang, Tae-Kyung Kim · 2021 · Science Advances
71. Nuclear Phosphatidylinositol 3,4,5-Trisphosphate Interactome Uncovers an Enrichment in Nucleolar Proteins
    Fatemeh Mazloumi Gavgani, Malene Skuseth Slinning, Andrea Papdiné Morovicz, Victoria Smith Arnesen, Diana Cornelia Turcu, Sandra Ninzima, Clive S. D’Santos, Aurélia E. Lewis · 2021 · Molecular & Cellular Proteomics
72. A dominant-negative SOX18 mutant disrupts multiple regulatory layers essential to transcription factor activity
    Alex J. McCann, Jieqiong Lou, Mehdi Denis Moustaqil, Matthew S. Graus, Ailisa Blum, Frank R. Fontaine, Hui Liu, Winnie Luu, Paulina Rudolffi-Soto, Peter A. Koopman et al. · 2021 · Nucleic Acids Research
73. Genetic Regulation of Transcription in the Endometrium in Health and Disease
    Sally Mortlock, Brett David McKinnon, Grant W. Montgomery · 2022 · Frontiers in Reproductive Health
74. Feed-forward transcriptional programming by nuclear receptors: Regulatory principles and therapeutic implications
    Sarah K. Sasse, Anthony N. Gerber · 2014 · Pharmacology & Therapeutics
75. Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer
    Annamaria Salvati, Valerio Gigantino, Giovanni Nassa, Valeria Mirici Cappa, Giovanna Maria Ventola, Daniela Georgia Cristina Cracas, Raffaella Mastrocinque, Francesca Maria Rizzo, Roberta Tarallo, Alessandro Weisz et al. · 2020 · International Journal of Molecular Sciences
76. Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancer.
    I. Mayayo-Peralta, S. Preković, W. Zwart · 2020 · Molecular Aspects of Medicine
77. Epigenetic remodelling of enhancers in response to estrogen deprivation and re-stimulation
    Athéna Sklias, Andrea Halaburková, Ludovica Vanzan, Nora Fernandez Jimenez, Cyrille Cuenin, Liacine Bouaoun, Vincent Cahais, Victor Ythier, Aurèlie Sallé, Claire Renard et al. · 2021 · Nucleic Acids Research
78. Analyzing the Androgen Receptor Interactome in Prostate Cancer: Implications for Therapeutic Intervention
    Ujjwal Ranjan Dahiya, Hannelore V. Heemers · 2022 · Cells
79. PAXIP1 and STAG2 converge to maintain 3D genome architecture and facilitate promoter/enhancer contacts to enable stress hormone-dependent transcription
    I. Mayayo-Peralta, S. Gregoricchio, K. Schuurman, Selçuk Yavuz, Anniek Zaalberg, A. Kojic, Nina Abbott, Bart Geverts, S. Beerthuijzen, Joseph C. Siefert et al. · 2023 · Nucleic Acids Research
80. A ChIP on the shoulder? Chromatin immunoprecipitation and validation strategies for ChIP antibodies
    Fiona C. Wardle, Haihan Tan · 2015 · F1000Research
81. Family Matters: Collaboration and Conflict Among the Steroid Receptors Raises a Need for Group Therapy
    Matthew J. Sikora · 2016 · Endocrinology
82. Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines
    Thomas L. Gonzalez, Rebecca K. Moos, Christina L. Gersch, Michael D. Johnson, Rudy J. Richardson, Holger Martin Koch, James Michael Rae · 2018 · Toxicological Sciences
83. Exploring Protein–Protein Interaction in the Study of Hormone-Dependent Cancers
    Y. Miki, Erina Iwabuchi, K. Ono, H. Sasano, Kiyoshi Ito · 2018 · International Journal of Molecular Sciences
84. Lipophilic statins inhibit growth and reduce invasiveness of human endometrial stromal cells
    Anna Sokalska, Amanda B. Hawkins, Toshia Yamaguchi, Antoni J. Dulęba · 2018 · Journal of Assisted Reproduction and Genetics
85. Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alpha
    Silvia Glont, Evangelia K. Papachristou, Ashley Sawle, Kelly A. Holmes, Jason S. Carroll, Rasmus Siersbæk · 2019 · PLoS ONE
86. ELF5 modulates the estrogen receptor cistrome in breast cancer
    Catherine Blyth, Daniel Lee Roden, Andrew M. K. Law, Mark P. Molloy, Christoph Krisp, Alexander Swarbrick, Matthew J. Naylor, Maria Kalyuga, Warren H. Kaplan, Samantha Richelle Oakes et al. · 2020 · PLoS Genetics
87. The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
    Leila Hosseinzadeh, Zoya Kikhtyak, Geraldine Laven‐Law, Stephen Pederson, Caroline G. Puiu, Clive S. D’Santos, Elgene Lim, Jason S. Carroll, Wayne D. Tilley, Amy R. Dwyer et al. · 2024 · Genome biology
88. The first decade of estrogen receptor cistromics in breast cancer
    Koen D. Flach, Wilbert T. Zwart · 2016 · Journal of Endocrinology
89. T‐cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases
    Mareike Doerrenberg, Andreas Kloetgen, Kebria Hezaveh, Wilhelm Wößmann, Kirsten Bleckmann, Martin Stanulla, Martin Schrappe, Alice Carolyn McHardy, Arndt Borkhardt, Jessica I. Hoell · 2016 · Genes Chromosomes and Cancer
90. GREB1 isoforms regulate proliferation independent of ERα co-regulator activities in breast cancer
    Corinne N. Haines, Kara M. Braunreiter, Xiaokui Molly Mo, Craig J. Burd · 2018 · Endocrine Related Cancer
91. PPARβ/δ recruits NCOR and regulates transcription reinitiation of ANGPTL4
    Nathalie Legrand, Clemens Bretscher, Svenja Zielke, Bernhard Wilke, Michael Daude, Barbara Fritz, Wibke E. Diederich, Till Adhikary · 2019 · Nucleic Acids Research
92. GREB1 regulates PI3K/Akt signaling to control hormone-sensitive breast cancer proliferation
    Corinne N. Haines, Hope D Klingensmith, Makanko Komara, Craig J. Burd · 2020 · Carcinogenesis
93. Estrogen receptor alpha: Molecular mechanisms and emerging insights
    Nicholes R. Candelaria, Liu Ka, Chin‐Yo Lin · 2013 · Journal of Cellular Biochemistry
94. NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells
    Edina Erdős, Bálint L. Bálint · 2020 · International Journal of Molecular Sciences
95. Kaposi’s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters
    Yoshihiro Izumiya, Adhraa Algalil, Jonna Magdallene Espera, Hiroki Miura, Chie Izumiya, Tomoki Inagaki, Ashish Kumar · 2024 · Journal of Virology
96. Protein-Protein Interaction Detection Via Mass Spectrometry-Based Proteomics
    Benedetta Turriziani, Alex von Kriegsheim, Stephen R. Pennington · 2016 · Advances in experimental medicine and biology
97. greb1 regulates convergent extension movement and pituitary development in zebrafish
    Shi-Zhu Li, Wei Liu, Zhi Li, Wenhua Li, Yang Wang, Li Zhou, Jian‐Fang Gui · 2017 · Gene
98. The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer–promoter interactions
    Zhangwei Tong, Yonghong Liu, Xiaobin Yu, Jarrod D. Martinez, Jianming Xu · 2019 · Journal of Biological Chemistry
99. Identification of molecular markers in pectoral fin to predict artificial maturation of female European eels (Anguilla anguilla)
    Ron P. Dirks, Erik Burgerhout, Sebastiaan A. Brittijn, Daniëlle L. de Wijze, Hulya Ozupek, Nynke Tuinhof-Koelma, Yuki Minegishi, Susanne A. Jong-Raadsen, Herman P. Spaink, Guido E.E.J.M. van den Thillart · 2014 · General and Comparative Endocrinology
100. Zfhx3 is essential for progesterone/progesterone receptor signaling to drive ductal side-branching and alveologenesis in mouse mammary glands
     Gui Ma, Ang Gao, Yinan Yang, Yuan He, Xi Zhang, Baotong Zhang, Zhiqian Zhang, Mei Li, Xing Fu, Dan Zhao et al. · 2019 · Journal of genetics and genomics/Journal of Genetics and Genomics